1 / 14

Anticoagulants Market 2022: Industry Overview, Growth Rate and Forecast 2027

Looking forward, the anticoagulants market value is projected to reach a strong growth during the forecast period (2022-2027).<br>More info:- https://www.imarcgroup.com/anticoagulants-market

21058
Download Presentation

Anticoagulants Market 2022: Industry Overview, Growth Rate and Forecast 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Anticoagulants Market Research and Forecast Report 2022- 2027 Author: Elena Anderson Marketing Manager Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2022 IMARC All Rights Reserved

  2. Report DescriptionAbout IMARC Group International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

  3. Report Description and Highlights Report Description Global Anticoagulants Market Research Report 2022-2027: The latest report by IMARC Group, titled “Anticoagulants Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2027,” finds that the global anticoagulants market size reached a value of US$ 34.0 Billion in 2021. Anticoagulants, also known as blood thinners, are chemical substances that prevent or reduce the coagulation of blood and extend the blood clotting time. They are utilized to minimize the risk of blood clots in various medical conditions, such as myocardial infarction, deep vein thrombosis, pulmonary embolism, and stroke. These drugs are usually available in capsule or tablet form, including warfarin, rivaroxaban, dabigatran, and apixaban. Owing to these properties, doctors widely prescribe anticoagulants to people who are at a high risk of clot formation. Request for a PDF sample of this report: https://www.imarcgroup.com/anticoagulants- market/requestsample

  4. Report Description and Highlights Report Description Global Anticoagulants Market Trends: The market is primarily driven by the rising incidences of hypercoagulability across the globe. According to studies, hypercoagulability in individuals affected by the coronavirus disease (COVID-19) pandemic can be one of the leading causes of mortality, which is escalating the demand for anticoagulants. In addition, the growing prevalence of human immunodeficiency virus (HIV), hepatitis C, Lyme disease, obesity, cancer, and chronic inflammation, represents another major growth-inducing factor. Besides this, extended sitting, smoking, trauma, blood disorders, and autoimmune diseases can cause blood clotting in different parts of the body. This, coupled with the improving diagnosis rates and the rising adoption of target therapeutics, is positively influencing the market growth. Furthermore, the surging number of surgeries requiring prolonged bed rest also increases the risk of blood clots among individuals, thus propelling the market growth. Looking forward, IMARC Group expects the market to reach a value of US$ 60.8 Billion by 2027, exhibiting a CAGR of 10.2% during the forecast period (2022-2027). View Report TOC, Figures and Tables: https://www.imarcgroup.com/anticoagulants-market

  5. Report Description and Highlights Report Description Key Market Segmentation The research report includes the following segments: Breakup by Drug Class: •Novel Oral Anticoagulants (NOACs) •Heparin and Low Molecular Weight Heparin (LMWH) •Vitamin K Antagonist •Others Breakup by Route of Administration: •Oral Anticoagulant •Injectable Anticoagulant Breakup by Distribution Channel: •Hospital Pharmacies •Retail Pharmacies •Online Stores •Others

  6. Report Description and Highlights Report Description Breakup by Application: •Atrial Fibrillation and Heart Attack •Stroke •Deep Vein Thrombosis (DVT) •Pulmonary Embolism (PE) •Others Breakup by Region: •North America •Asia Pacific •Europe •Latin America •Middle East and Africa

  7. Report Description and Highlights Report Description Competitive Landscape with Key Players: •Alexion Pharmaceuticals Inc •Aspen Holdings •Bayer AG •Boehringer Ingelheim International GmbH •Bristol-Myers Squibb Company •Daiichi Sankyo Company Limited •Dr. Reddy’s Laboratories Ltd •GlaxoSmithKline plc •Johnson & Johnson Private Limited •Pfizer Inc. •Sanofi.

  8. Key Questions Answered in the Report Report Description 1. How has the global anticoagulants market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global anticoagulants market? What are the key regional markets? What is the breakup of the market based on the drug class? What is the breakup of the market based on the route of administration? What is the breakup of the market based on the distribution channel? What is the breakup of the market based on the application? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? 10. What is the structure of the global anticoagulants market and who are the key players? 11. What is the degree of competition in the industry? 2. 3. 4. 5. 6. 7. 8. 9.

  9. Report DescriptionTable of Contents 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Anticoagulants Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast

  10. Report DescriptionTable of Contents 6 Market Breakup by Drug Class 6.1 Novel Oral Anticoagulants (NOACs) 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Heparin and Low Molecular Weight Heparin (LMWH) 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Vitamin K Antagonist 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Others 6.4.1 Market Trends 6.4.2 Market Forecast 7 Market Breakup by Route of Administration 7.1 Oral Anticoagulant 7.1.1 Market Trends 7.1.2 Market Forecast Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/anticoagulants-market/toc

  11. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

  12. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

  13. Report Description and Highlights Report Description © 2022 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

  14. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com

More Related